- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Skyepharma Share News (SKP)
Share News for Skyepharma (SKP)
| Share Price: 50.50 | Bid: 50.00 | Ask: 54.00 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
Skyepharma says FDA filing for Flutiform could be delayed to H2 2008
LONDON (Thomson Financial) - Skyepharma PLC said it expects the New Drug Application for its Flutiform product to treat asthma to be delayed to[6 Aug '07]
Skyepharma says expectations for 2007 unchanged; Flutiform on track
LONDON (Thomson Financial) - Skyepharma PLC said there has been no 'material change' in expectations for the operating result for 2007, although[29 Jun '07]
Skyepharma licenses sleep drug SKP-1041 to Somnus, to get 35 mln usd in payments
LONDON (Thomson Financial) - Skyepharma PLC said it has licensed its sleep drug, SKP-1041 to Somnus Therapeutics adding it will receive up to 35[26 Jun '07]
Skyepharma says FDA approves Zyflo CR asthma drug that uses its technology
LONDON (Thomson Financial) - Skyepharma PLC said the US Food and Drug Administration has approved asthma drug Zyflo CR which uses the company's[31 May '07]
Skyepharma says successfully completes trial for new formulation of Sular(R)
LONDON (Thomson Financial) - Skyepharma PLC and Sciele Pharma Inc said they have successfully completed the clinical trial for the new formulati[14 May '07]
Skyepharma to delist from NASDAQ to save costs
LONDON (Thomson Financial) - British drug reformulation group Skyepharma PLC plans to delist its shares from trading in the US on NASDAQ, to sav[4 May '07]
Skyepharma annual losses widen UPDATE
(Adds further comment, detail) LONDON (Thomson Financial) - Skyepharma PLC reported widening losses for the year on the cost of developing i[26 Apr '07]
Skyepharma annual losses widen UPDATE
(Adds further detail, company comment) LONDON (Thomson Financial) - Skyepharma PLC reported widening losses for the year on the cost of the[26 Apr '07]
